- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Earache.
Displaying page 1 of 1.
EudraCT Number: 2014-004016-11 | Sponsor Protocol Number: 2305 | Start Date*: 2016-06-30 | ||||||||||||||||
Sponsor Name:University of Bristol | ||||||||||||||||||
Full Title: What is the clinical and cost effectiveness of benzocaine/phenazone ear drops for reducing antibiotic consumption and ear pain in children aged between 6 months and 10 years presenting to primary c... | ||||||||||||||||||
Medical condition: Acute otitis media | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-012640-17 | Sponsor Protocol Number: KJos/FIN | Start Date*: 2009-12-10 |
Sponsor Name:Swedish Herbal Institute | ||
Full Title: A randomized, controlled, parallel-group, double-blind study of the proprietary Kan Jang Oral Solution versus placebo in patients with non complicated respiratory tract infections (common cold). | ||
Medical condition: common cold | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003194-33 | Sponsor Protocol Number: VAC18193RSV2002 | Start Date*: 2017-10-03 |
Sponsor Name:Janssen Vaccines and Prevention B.V. | ||
Full Title: An Exploratory, Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infe... | ||
Medical condition: Prophylactic respiratory syncytial virus (RSV) vaccine. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002287-16 | Sponsor Protocol Number: GS-US-218-1797 | Start Date*: 2015-10-15 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients with Respiratory Syncytial Virus (RSV) Infection | |||||||||||||
Medical condition: Respiratory Syncytial Virus (RSV) Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) AT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002455-97 | Sponsor Protocol Number: 13381 | Start Date*: 2016-10-19 | ||||||||||||||||
Sponsor Name:University of Southampton | ||||||||||||||||||
Full Title: Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care | ||||||||||||||||||
Medical condition: Respiratory tract infections in children aged between 6 months and 12 years | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002137-58 | Sponsor Protocol Number: GS-US-218-1227 | Start Date*: 2014-09-29 | |||||||||||
Sponsor Name:Gilead Sciences Inc | |||||||||||||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hospitalized Adults with Respirato... | |||||||||||||
Medical condition: Respiratory Syncytial Virus (RSV) Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) IT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001103-31 | Sponsor Protocol Number: AIT02-2001/DMID14-005 | Start Date*: 2015-07-10 | |||||||||||
Sponsor Name:Autoimmune Technologies, LLC | |||||||||||||
Full Title: A Phase 2a, Randomized, Double-blind, Placebo-controlled Assessment of the Safety and Protective Efficacy of FF-3 Dry Powder Administered by Nasal Inhalation for 5 Days to Healthy Adult Subjects wh... | |||||||||||||
Medical condition: Influenza A infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004923-34 | Sponsor Protocol Number: RSV-MVA-004 | Start Date*: 2022-07-07 | |||||||||||
Sponsor Name:Bavarian Nordic A/S | |||||||||||||
Full Title: A Randomized, Double-blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN®-RSV Vaccine in Adults ≥60 Years of Age | |||||||||||||
Medical condition: respiratory syncytial virus disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001529-30 | Sponsor Protocol Number: EDP938-102 | Start Date*: 2020-09-29 | |||||||||||
Sponsor Name:Enanta Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of EDP-938 Administered Orally for the Treatment of Acute Upper Respiratory Tract Infection with Respiratory Syncytial Virus in Ambula... | |||||||||||||
Medical condition: Respiratory syncytial virus (RSV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002213-18 | Sponsor Protocol Number: EDP938-103 | Start Date*: 2020-11-05 | |||||||||||
Sponsor Name:Enanta Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of EDP-938 in Adult Hematopoietic Cell Transplant Recipients With Acute Respiratory Syncytial Virus Infection o... | |||||||||||||
Medical condition: Respiratory syncytial virus (RSV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Prematurely Ended) BE (Completed) PL (Prematurely Ended) GR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.